Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment.

ABSTRACT:

Introduction

The objective of this report is to describe the clinical pathway for early treatment of patients with acute SARS-CoV-2 infection and to evaluate the first results of its implementation.

Methods

This is a descriptive and retrospective study of the implementation of a clinical pathway of treatment in outpatients (January 1 to June 30 2022). Clinical pathway: detection and referral systems from Primary Care, Emergency services, hospital specialities and an automated detection system; clinical evaluation and treatment administration in the COVID-19 day-hospital and subsequent clinical follow-up. Explanatory variables: demographics, comorbidity, vaccination status, referral pathways and treatment administration.

Outcome variables

hospitalization and death with

SUBMITTER: Pinargote-Celorio H 

PROVIDER: S-EPMC10063154 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature